Brief: Can-Fite's Piclidenoson Commences Clinical Study For Treatment Of Canine Osteoarthritis

Can Fite Biopharma

23/11/2021 12:27

Nov 23 (Reuters) - Can Fite Biopharma Ltd  CANF.TA :
    * CAN-FITE'S PICLIDENOSON COMMENCES CLINICAL STUDY FOR
TREATMENT
OF CANINE OSTEOARTHRITIS
    * CAN FITE BIOPHARMA LTD - SAFETY RESULTS ARE EXPECTED Q1
2022 AND
EFFICACY DATA IS EXPECTED Q4 2022.

Source text for Eikon:  ID:nBw8Z5b5ka 
Further company coverage:  CANF.TA 

 ((Reuters.Briefs@thomsonreuters.com;;))